Bioventus (BVS) Cost of Revenue (2020 - 2026)
Bioventus' (BVS) quarterly Cost of Revenue came in at $41.3 million in Q1 2026, up 1.22% YoY from $40.8 million in Q1 2025, and down 15.88% on a QoQ basis from $49.1 million in Q4 2025.
Bioventus (BVS) Cost of Revenue (2020 - 2026) Analysis & Trends
Bioventus (BVS) has 7 years of Cost of Revenue data on file, last reported at $41.3 million in Q1 2026.
- Quarterly Cost of Revenue rose 1.22% year-over-year to $41.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $180.4 million (down 2.36% YoY) and the FY2025 annual result came in at $179.9 million, down 2.77% from the prior year.
- Cost of Revenue slipped to $41.3 million in Q1 2026, from $49.1 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $51.6 million in Q4 2022 to a low of $40.8 million in Q1 2025.
- A 5-year average of $45.4 million and a median of $45.1 million in 2023 frame the typical range for Cost of Revenue.
- Annual changes were most pronounced in 2022 — Cost of Revenue jumped 87.15% — and 2024, when it fell 9.0%.
- Tracing BVS's Cost of Revenue over 5 years: stood at $51.6 million in 2022, then fell by 4.89% to $49.1 million in 2023, then advanced by 3.79% to $51.0 million in 2024, then dropped by 3.66% to $49.1 million in 2025, then slipped by 15.88% to $41.3 million in 2026.
- The last three Cost of Revenue figures came in at $41.3 million (Q1 2026), $49.1 million (Q4 2025), and $44.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 2.09 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 392.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 478.40 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 2.57 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 808.60 Mn |
| 10 | Bioventus | 976.64 Mn | 947.18 Mn | 105.67 Mn | 47.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 47.54 Mn |
| Jun 27, 2026 | 47.54 Mn |
| Mar 28, 2026 | 41.32 Mn |
| Mar 28, 2026 | 41.32 Mn |
| Dec 31, 2025 | 49.12 Mn |
| Dec 31, 2025 | 49.12 Mn |
| Sep 27, 2025 | 44.42 Mn |
| Sep 27, 2025 | 44.42 Mn |
| Jun 28, 2025 | 45.57 Mn |
| Jun 28, 2025 | 45.57 Mn |
| Mar 29, 2025 | 40.82 Mn |
| Mar 29, 2025 | 40.82 Mn |
| Dec 31, 2024 | 50.99 Mn |
| Dec 31, 2024 | 50.99 Mn |
| Sep 28, 2024 | 45.41 Mn |
| Sep 28, 2024 | 45.41 Mn |
| Jun 29, 2024 | 47.58 Mn |
| Jun 29, 2024 | 47.58 Mn |
| Mar 30, 2024 | 41.08 Mn |
| Mar 30, 2024 | 41.08 Mn |